Trials / Completed
CompletedNCT01370681
A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject
An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics After Administration of CJ30001 and Co-administration of HKB0701/SLM0807 in Korean Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to demonstrate the bioequivalence of CJ30001(fixed-dose combination tablet of HKB0701 and SLM0807) relative to HKB0701 and SLM0807 co-administered to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Period I : HKB0701 and SLM0807, Period II : CJ30001 | |
| DRUG | Period I : CJ30001, Period II : HKB0701 and SLM0807 |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2011-06-10
- Last updated
- 2011-06-10
Source: ClinicalTrials.gov record NCT01370681. Inclusion in this directory is not an endorsement.